Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-30 @ 3:37 AM
Study NCT ID:
NCT01491295
Status:
UNKNOWN
Last Update Posted:
2016-04-01
First Post:
2011-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
Sponsor:
Taipei Veterans General Hospital, Taiwan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2019-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12
Completion Date Type:
ESTIMATED
First Submit Date:
2011-10-27
First Submit QC Date:
None
Study First Post Date:
2011-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-31
Last Update Post Date:
2016-04-01
Last Update Post Date Type:
ESTIMATED